Deep Dive: Domino’s Pizza ($DPZ)

In December of 2009, with the global economy recovering from the financial crisis, Domino’s Pizza did something almost no large consumer brand had ever done. It went on national TV and admitted its pizza tasted bad. One focus-group customer called it the worst excuse for pizza they had ever had. The company put that footage in its own ads and rebuilt the recipe.

17 years later, Domino’s has grown into one of the most successful QSR brands in the world. It has posted 11 straight years of U.S. market share gains and 32 consecutive years of international same-store sales growth (SSSG).

Domino’s today has 99% of its stores franchised (capital-light business model) and $20 billion in global system sales. While Pizza Hut and Papa John’s close stores by the hundreds, Domino’s adds them. The question in May 2026 is not whether the business is great. It is whether the stock, down ~35% from its summer 2025 peak of ~$495, is finally cheap enough to own.

The short answer: Domino’s is not a screaming bargain. But the downside risk is low, and the >6% free cash flow yield is very lucrative. The key question for Rebound Capital is whether Domino’s business is in structural decline.

Welcome to Rebound Capital. If you are new here, we conduct in-depth research on beaten-down stocks and study companies that have made successful comebacks. Subscribe for free and join 21,700+ other investors to make sure you don’t miss our next briefing.

Domino’s trades at ~$310. Our bottom-up DCF intrinsic value is $290 (7% discount rate, 20x terminal EV/FCF). On paper, you are paying a small premium to fair value. But that is just one valuation method.

Another one is the total return breakup. At today’s price, Domino’s offers a ~6.3% trailing FCF yield and ~2% projected FCF growth over five years. That compounds to an expected 5-year return of ~8% per year if the valuation multiple remains the same. Adding the free cash flow yield (at today’s price) to the free cash flow growth CAGR over a period of time is a rough method for calculating a stock’s expected return (if its valuation multiples remain constant) over that period.

An 8% return is not too exciting, but the interesting thing here is that most of that 8% comes from free cash flow, not free cash flow growth. This is the kind of stock value investors would buy - with decent returns just from the free cash flow (they don’t like depending on or paying for growth).

Note: The above is an example, and we are not giving any advice. Also, the above calculations hold only for cases where free cash flow is growing.

Domino’s is three businesses with different drivers and margins, bound together by a shared customer base and brand.

This is the most underappreciated piece of the company. Domino’s runs 25 vertically integrated dough manufacturing and food distribution centers across the U.S. and Canada. They produce dough, cheese, sauce, and toppings, and deliver twice a week to every U.S. franchise store. Franchisees are required to buy from the supply chain at a markup over food cost.

The margin story is what to watch. Supply chain gross margin expanded from 10.6% in Q3 2024 to 11.3% in Q3 2025, despite the food basket inflation. Domino’s procurement is at a scale that no other pizza chain can replicate. For example, Papa John’s franchisees source mozzarella locally and pay 6%-10% more for it.

This has 3 revenue streams sharing a single driver: U.S. system retail sales. Basically, Domino’s makes a royalty on each dollar of sales done by its franchisee restaurants in the US. It also earns revenue from its own stores.

U.S. royalties and fees were ~$660M in 2025, at a ~5.5% royalty rate, carrying 90%+ operating margins. This is the company’s highest-quality line. Advertising fund revenue (~$514M) is pure pass-through and should be ignored for valuation purposes. Company-owned stores (~$342M, ~252 stores) are deliberately shrinking. Management is reducing the company's owned stores to ~150 by 2028, which is margin-accretive.

The smallest line, but proportionally the highest-quality cash flow. Domino’s owns no international stores. It collects royalties from master franchisees: Jubilant FoodWorks (India), DPC Dash (China), Alsea (Mexico), and Domino’s Pizza Enterprises (Australia/Japan). Operating margins are essentially 100% incremental. International had a negative SSSG% in Q1 2026 (-0.4% SSS ex-FX), dragged almost entirely by Australia/Japan. Before that, for >30 years, international sales have had positive SSSG%.

The takeaway: two-thirds of Domino’s revenue scales linearly with global system sales at near-100% incremental margins.

The stock recently peaked at ~$495 in summer 2025 and now sits at ~$310. Three things drove the drawdown:

U.S. same-store sales came in at +0.9% against management’s previously guided 3% for the year. On the Q1 2026 call (April 27), management softened the guidance to a positive low single-digit range. They blamed this on ‘Covid-level’ consumer confidence, inflation, and price competition from competitors.

This was the first evidence that the broader QSR slowdown, driven by weak consumer confidence (for various reasons), is finally biting into Domino’s value proposition.

10 million U.S. adults are now taking GLP-1 drugs, up from 5 million in 2023. This number will increase to 30 million by 2030, according to JP Morgan estimates. This may be an underestimation, in my humble opinion. As better drugs come out, more and more people who are not obese may start taking these drugs for looking good/getting ripped (not kidding and not endorsing this either).

A Cornell / Journal of Marketing Research study found GLP-1 users spend 8% less on QSR meals than non-users. The market is pricing in demand compression. This has been a negative overhang on the stock for at least 1 year. This affects its terminal value multiple and is the main structural headwind to Domino’s business. Here is another article looking at how GLP-1 drugs affect eating habits.

International SSSG% was -0.4% vs. an expectation of 0.7% rise. Domino’s Pizza Enterprises (Australia/Japan) missed Q1 expectations. Domino’s in India (a large growth market with ~2,100 stores) has seen SSSG growth stall amid weak consumer spending.

The selloff was rational. The question is whether it has gone too far.

This is the central question for any DPZ investor. Our verdict is that the moat is wide and modestly deepening.

Store-level economics: A Domino’s franchisee generates ~$1.36M in AUV (annual sales for 1 restaurant). Pizza Hut and Papa John’s franchisees average ~$1M. When a competitor closes a store, those locations add an AUV of ~$500k. The consumer doesn’t lose access to pizza in that case. They just switch chains, and Domino’s captures them. Franchisee ROIC at Domino’s is consequently higher than at Pizza Hut and Papa John’s.

Supply chain scale: 25 plants serving 22,150 stores create buying power no competitor can match. Procurement productivity expanded the supply chain gross margin by 70bps (0.7%) in 2025 despite food inflation. As Domino’s adds another ~5,000 stores by 2030, the gap widens.

Technology stack: 1,600+ DJ dough-stretching machines automate the most labor-intensive step of pizza making. The average delivery time has dropped by 2 minutes over the past 2 years. Dom.OS is the proprietary in-store operating system and is considered the gold standard. Then there is the technology that enables efficient delivery.

Delivery Ecosystem: Domino’s has 37M+ loyalty members, to whom pizza is delivered directly through Domino’s own delivery partners and who order through the Domino’s app. The recent DoorDash partnership (May 2025) plugged the one channel where Domino’s had been absent. In Q3 2025, the first full quarter on DoorDash, revenue showed measurable uplift.

GLP-1 acceleration: Our base case assumes rapid global GLP-1 penetration. Oral formulations and future drugs with fewer side effects can shrink the pizza category in absolute terms, not just slow down growth. This is the biggest risk. If GLP-1 compresses category demand sharply, the FCF yield framework breaks down

Aggregator platforms: DoorDash and Uber Eats are platforms, not direct competitors. But by serving as a discovery layer, they level the playing field for smaller chains (like Marco’s and Mountain Mike’s) and independents. If algorithm changes start steering DoorDash users toward independent pizzerias, the playing field flattens.

Generational drift: YouGov’s August 2025 ranking of Gen Z purchase intent places Domino’s at #8 in QSR, behind McDonald’s, Chick-fil-A, KFC, Taco Bell, Subway, Wendy’s, and Dairy Queen. 61% of Gen Z agree that dining out is a treat reserved for special occasions. 73% want to try new cuisines. Pizza is the opposite of culinary novelty. This can be a drag on the business growth.

Net assessment: We estimate that Domino’s moat remains intact, especially versus other Pizza chains. The macro factors affecting the business are structural headwinds: GLP-1 drugs, aggregator platforms negating Domino’s app strategy, and a weak consumer (AI job losses could prolong consumer weakness).

Pizza Hut’s parent, Yum Brands, has announced 250 underperforming closures in H1 2026 and has reportedly been considering a sale of the brand. Papa John’s plans to close 300 stores by the end of 2027, with 200 of those in 2026. Domino’s added 172 net new U.S. stores in 2025 and should be able to add 500-650 stores through 2030. Domino’s net new U.S. unit growth from 2019 through Q3 2025 ranks #1 across all public QSR brands of 3,000+ restaurants, pizza or otherwise. Its U.S. QSR pizza share has gone from 12% in 2014 to 23.3% in 2025, gaining roughly 100bps per year.

CEO Russell Weiner’s stated ambition is to double retail sales. We treat that as aspirational. But a 30 to 35% share by 2035 is a realistic glide path (in the US) on the current trajectory (continuing to gain 1% market share per year).

The market is pricing Domino’s at a meaningful discount to its 5-year average multiple of ~22x and to the multiples of quality QSR peers (CMG at ~30x, MCD at ~23x, WING at ~30x). The 18x entry multiple reflects post-Q1 disappointment and concerns about GLP-1.

Below is our comprehensive driver-based bottom-up model for DPZ, which includes segment-level forecasts and the DCF. DPZ’s intrinsic value is ~$290 per share.

We are giving DPZ a ‘HOLD’ rating. We expect Domino’s to remain a low-growth company with the added overhang of newer varieties of GLP-1 drugs (which may not have the side effects current drugs have - hence much worse for QSRs). On top of that, consumer spending can remain under pressure due to AI-related job losses. The high FCF yield reflects the market's recognition of the risks.

The international division will drive the majority of its growth. In the US, if competitors turn around, most of Domino’s expected share gains may evaporate. Given structural issues such as GLP-1 drug usage and weak US/International consumer spending (which show no signs of improvement), we will stay on the sidelines.

If the stock falls below $275, we will begin a starter position (~2%). At that price (~20x EV/FCF), the negatives will be more than fully priced in, and the stock will be ~10% below RC’s intrinsic value estimate (which itself is conservative).

To doctors, nutritionists, and others with knowledge of GLP-1 drugs, please help us understand how this trend will unfold. If we can negate the GLP-1 anti-thesis pointer, we can be better informed while researching QSR/consumer discretionary stocks. If this is not a structural threat, then Domino’s flips to a ‘BUY’ rating for my portfolio.

That’s it for now. If you are here, please ♡ Like this piece. It helps us massively!

Rebound Capital’s work is provided for informational purposes only and should not be construed as legal, business, investment, or tax advice. You should always do your own research.